Krishna Institute of Medical Sciences Ltd
Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.
- Market Cap ₹ 27,295 Cr.
- Current Price ₹ 682
- High / Low ₹ 798 / 576
- Stock P/E 97.4
- Book Value ₹ 57.2
- Dividend Yield 0.00 %
- ROCE 16.0 %
- ROE 14.0 %
- Face Value ₹ 2.00
Pros
Cons
- Stock is trading at 11.9 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 11.9% over past five years.
- Promoter holding has decreased over last 3 years: -4.73%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Select Index BSE 250 SmallCap Index
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 485 | 536 | 628 | 707 | 790 | 933 | 1,143 | 1,132 | 1,222 | 1,384 | 1,591 | |
| 380 | 422 | 562 | 652 | 584 | 624 | 740 | 768 | 857 | 963 | 1,145 | |
| Operating Profit | 104 | 114 | 66 | 55 | 206 | 309 | 403 | 364 | 366 | 421 | 446 |
| OPM % | 22% | 21% | 10% | 8% | 26% | 33% | 35% | 32% | 30% | 30% | 28% |
| 4 | 3 | 3 | 6 | 7 | 8 | 21 | 23 | 18 | 68 | 74 | |
| Interest | 36 | 32 | 88 | 33 | 24 | 18 | 9 | 5 | 7 | 28 | 60 |
| Depreciation | 34 | 34 | 38 | 41 | 43 | 45 | 45 | 45 | 58 | 58 | 76 |
| Profit before tax | 38 | 51 | -57 | -13 | 147 | 254 | 371 | 337 | 318 | 403 | 384 |
| Tax % | 37% | 37% | 43% | 225% | 17% | 26% | 25% | 25% | 26% | 25% | |
| 24 | 33 | -81 | -44 | 121 | 189 | 278 | 252 | 235 | 303 | 288 | |
| EPS in Rs | 0.69 | 0.91 | -2.27 | -1.17 | 3.25 | 4.86 | 6.96 | 6.31 | 5.88 | 7.57 | 7.21 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 7% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 0% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 31% |
| 1 Year: | 4% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 15% |
| Last Year: | 14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 70 | 72 | 50 | 74 | 74 | 78 | 80 | 80 | 80 | 80 | 80 |
| Reserves | 191 | 252 | -249 | 429 | 550 | 830 | 1,298 | 1,551 | 1,786 | 2,088 | 2,210 |
| 251 | 277 | 666 | 187 | 186 | 131 | 18 | 4 | 326 | 708 | 1,052 | |
| 134 | 153 | 323 | 166 | 147 | 175 | 173 | 177 | 204 | 313 | 329 | |
| Total Liabilities | 646 | 753 | 789 | 857 | 957 | 1,214 | 1,569 | 1,812 | 2,397 | 3,189 | 3,671 |
| 498 | 501 | 576 | 567 | 559 | 582 | 592 | 612 | 674 | 773 | 1,349 | |
| CWIP | 2 | 64 | 0 | 0 | 2 | 8 | 13 | 16 | 292 | 530 | 92 |
| Investments | 18 | 22 | 31 | 80 | 178 | 213 | 542 | 826 | 1,062 | 1,226 | 1,291 |
| 128 | 167 | 182 | 210 | 218 | 411 | 422 | 358 | 368 | 660 | 940 | |
| Total Assets | 646 | 753 | 789 | 857 | 957 | 1,214 | 1,569 | 1,812 | 2,397 | 3,189 | 3,671 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 89 | 78 | 94 | 109 | 161 | 291 | 284 | 271 | 262 | 294 | |
| -39 | -99 | -52 | -99 | -108 | -317 | -375 | -238 | -569 | -627 | |
| -61 | 25 | -42 | -12 | -24 | 25 | 76 | -15 | 289 | 339 | |
| Net Cash Flow | -10 | 5 | 0 | -2 | 28 | 0 | -15 | 18 | -18 | 6 |
| Free Cash Flow | 57 | -20 | 50 | 63 | 140 | 219 | 215 | 150 | -58 | -12 |
| CFO/OP | 85% | 79% | 176% | 245% | 101% | 108% | 94% | 95% | 95% | 91% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 46 | 59 | 56 | 52 | 46 | 29 | 28 | 39 | 44 | 49 |
| Inventory Days | 35 | 43 | 39 | 42 | 44 | 30 | 38 | |||
| Days Payable | 192 | 205 | 189 | 161 | 158 | 155 | 118 | |||
| Cash Conversion Cycle | -111 | -103 | -94 | -68 | -68 | -96 | -52 | 39 | 44 | 49 |
| Working Capital Days | 11 | 26 | -72 | 2 | -4 | -29 | 6 | 12 | 3 | -23 |
| ROCE % | 15% | 6% | 3% | 23% | 30% | 31% | 23% | 17% | 16% |
Insights
In beta| Mar 2005 | Mar 2010 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Hospitals Number |
|
||||||||||
| ALOS (Average Length of Stay) Days |
|||||||||||
| ARPOB (Average Revenue Per Occupied Bed) INR |
|||||||||||
| Bed Capacity Number |
|||||||||||
| Inpatient (IP) Volume Number |
|||||||||||
| Occupancy Percentage % |
|||||||||||
| Operational Beds Number |
|||||||||||
| Outpatient (OP) Volume Number |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
1d - Postal ballot approved QIP equity issuance for fund raising on April 15, 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Apr - Regulation 74(5) depository compliance certificate for quarter ended 31 March 2026.
-
Pursuant To Provisions Of Regulation 30 Of The SEBI (LODR) Regulations, 2015, KIMS Swastha Private Limited ('The KIMS'), A Wholly-Owned Subsidiary Of Krishna Institute Of Medical Sciences Limited Has Entered Into Definitive Agreements With Avitis Super Speciality Hospitals Private Limited.
2 Apr - KIMS subsidiary signed 20-year O&M and sub-lease agreements for 210-bed Avitis hospital in Palakkad.
-
The Subsidiary Company Has Received An Order Under Section 143(3) Read With Sections 250 And 144B Of The Income-Tax Act In Which The Department Has Set Aside The Said Demand Notice And Accordingly The Amount Payable In Respect Of This Matter Is Rs.0/- (Zero).
31 Mar - Subsidiary SPANV received IT order dated 29/03/2026; demand set aside, amount payable Rs.0.
- Closure of Trading Window 26 Mar
Annual reports
Concalls
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022TranscriptAI SummaryPPT
-
May 2022Transcript PPT
-
May 2022TranscriptAI SummaryPPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Oct 2021TranscriptAI SummaryPPT
-
Aug 2021Transcript PPT
Regional Leadership
KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and AP, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The Group offers healthcare services in specialties and super specialties across more than 40 fields. [1]